Capula Management LTD West Pharmaceutical Services Inc Transaction History

Capula Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$318.29 - $392.21 $35,011 - $43,143	-110 Reduced 8.46%	1,190 $419,000
Q2 2023 Aug 14, 2023	SELL	$334.63 - $382.47 $80,311 - $91,792	-240 Reduced 15.58%	1,300 $497,000
Q1 2023 May 10, 2023	SELL	$232.5 - $346.47 $174,375 - $259,852	-750 Reduced 32.75%	1,540 $533,000
Q4 2022 Feb 14, 2023	SELL	$209.34 - $261.61 $282,609 - $353,173	-1,350 Reduced 37.09%	2,290 $538,000
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $895,731 - $1.25 Million	3,640 New	3,640 $896,000
Q3 2021 Nov 15, 2021	SELL	$363.01 - $468.47 $294,764 - $380,397	-812 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$284.77 - $363.2 $231,233 - $294,918	812 New	812 $291,000

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.